FriedL., BernardiniJ., JohnstonJ.R., PirainoB.Peritonitis influences mortality in PD patients (Abstract).J Am Soc Nephrol1995; 6: 530.
2.
BurkartJ., SchreiberM., TaborT., KorbetS., StallardR., andP.D.Collaborative Group. Prospective, multicenter evaluation of patient transfer from PD to HD in 1995 (Abstract).Perit Dial Int1996; 16(Suppl 2): S66.
3.
LupoA., TarchiniR., CancariniG.Long-term outcome in continuous ambulatory peritoneal dialysis: A 10 year survey by the Italian Cooperative Peritoneal Dialysis Study Group.Am J Kidney Dis1994; 24: 826–37.
4.
Canadian CAPD Clinical Trials Group.Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): A multi-centre randomized clinical trial comparing the y connector disinfectant system to standard systems.Perit Dial Int1989; 9: 159–63.
5.
HolleyJ.L., BernardiniJ., PirainoB.Infecting organisms in continuous ambulatory peritoneal dialysis patients on the y setAmJKidneyDis1994; 23: 569–73.
6.
PlumJ., SudkampS., GrabenseeB.Results of ultrasound assisted diagnosis of tunnel infections in continuous ambulatory peritoneal dialysis.Am J Kidney Dis1994; 23: 99–104.
7.
HolleyJ.L., FoulksC.J., MossA.H., WillardD.Ultrasound as a tool in the diagnosis and management of exit-site infections in patients undergoing continuous ambulatory peritoneal dialysis.Am J Kidney Dis1989; 14: 211–16.
8.
KorzetsZ., ErdbergA., GolanE.Frequent involvement of the internal cuff segment in CAPD peritonitis and exit-site infection -an ultrasound study.Nephrol Dial Transplant1996; 11: 336–9.
9.
GuptaB., BernardiniJ., PirainoB.Outcome of peritonitis associated with catheter infections in PD patients.Perit Dial Int1996; 16: S39.
10.
LuzarM.A., ColesG.A., FallerB.Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.New Engl J Med1990; 322: 505–9.
11.
LyeW.C., LeongS.O., van der StrattenJ., LeeE.J.C.Staphylococcus aureus CAPD-related infections are associated with nasal carriage. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1994; 10: 163–5.
12.
ZimmermanS.W., AhrensE., JohnsonC.A.Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.Am J Kidney Dis1991; 18: 225–31.
13.
BernardiniJ., PirainoB., HolleyJ., JohnstonJ.R., LutesR.A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site.Am J Kidney Dis1996; 27: 695–700.
14.
ColesG.A., for the Mupirocin Study Group. The effect of intranasal mupirocin on CAPD exit site infection (Ab stract).J Am Soc Nephrol1994; 5: 439.
15.
Perez-FontanM., Garcia-FalconT., RosalesM.Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: Long term results.Am J Kidney Dis1993; 22: 708–12.
16.
OxtonL.L., ZimmermanS.W., RoeckerE.B., WakeenM.Risk factors for peritoneal dialysis related infectionsPerit Dial Int1994; 14: 137–44.
17.
LyeW.C., LeongS.O., LeeE.J.C.Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD.Kidney Int1993; 43: 1357–62.
18.
SchwalbeR.S., StapletonJ.T., GilliganP.H.Emergence of vancomycin resistance in coagulase-negative staphy lococci.New Engl J Med1987; 316: 927–31.
